If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
Revolutionary cellular system delivers more capable results and reliable performance ORANGE COUNTY, Calif., Dec. 23 (HSMN NewsFeed) — Beckman Coulter, Inc. (NYSE: BEC ), a top developer, manufacturer, and marketer of products that simplify and au…
Devices, Diagnostics, FDA
Beckman Coulter, UniCel DxH 800
Posts from ‘December, 2008’
Beckman Coulter Announces FDA Clearance of UniCel(R) DxH 800
MediciNova Proposes to Acquire Avigen, Inc.
SAN DIEGO, Dec. 23, 2008 — (HSMN NewsFeed) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (NasdaqGM:MNOV ) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced …
Biopharmaceuticals, Mergers & Acquisitions
MediciNova, Avigen
Vicor Technologies Announces Appointment of Chief Accounting Officer
BOCA RATON, FL–Dec 22, 2008 — Vicor Technologies, Inc. (OTC BB:VCRT.OB ), anticipating commercialization of its patented PD2i medical device software, announces that Thomas J. Bohannon, CPA, has been appointed vice president and Chief Accounting Officer….
Devices, Monitoring, Cardiology, Personnel
Vicor Technologies, PD2i
St. Jude Pathology Acquires MediGuide
New platform technology to enhance St. Jude Medical’s atrial fibrillation and other growth programs ST. PAUL, Minn. & HAIFA, Israel–(HSMN NewsFeed)–St. Jude Medical, Inc. (NYSE: STJ ) and MediGuide Inc. today announced the signing of a definitive merg…
Devices, Mergers & Acquisitions
St. Jude Laboratory, MediGuide, gMPS, Pathology Positioning System
TransMolecular Receives Orphan Drug Designation for 131I-TM601 for the Treatment of Melanoma
CAMBRIDGE, MA-(HSMN NewsFeed)–TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its anti-cancer compound 131I-TM…
Biopharmaceuticals, Oncology, FDA
TransMolecular, TM601, 131I, malignant melanoma, glioma
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
First Imaging Agent Approved for Magnetic Resonance Angiography (MRA) in the U.S. LEXINGTON, Mass.–(HSMN NewsFeed)–EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX ), a biopharmaceutical company focused on discovering and developing novel therapeutics through …
Biopharmaceuticals, Radiology
EPIX Pharmaceuticals, Vasovist, gadofosveset trisodium, MRA agent
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
SOUTH SAN FRANCISCO, CA–(HSMN NewsFeed)–KaloBios Pharmaceuticals, Inc. today announced that the company has raised an additional $12 million in the second closing of its Series D venture financing, which along with the $20 million it raised in September …
Biopharmaceuticals, Venture Capital
KaloBios Pharmaceuticals, Baxter International
Major European Universities Choose Elekta to Deliver Advanced 3D Brain Mapping Tool for Research
STOCKHOLM, Sweden, Dec. 22 (HSMN NewsFeed) — Elekta Neuromag®, the world-leading equipment for non-invasive measurement of brain activity using magnetoencephalography (MEG) technology has been ordered by the Moscow Municipal University of Psychology…
Devices, Neurology
Elekta, Neuromag, magnetoencephalography
Biovail Enters into Commercial Alliance for Aplenzin
Agreement Reached with sanofi-aventis US Biovails Supply Price Ranges from 25% to 35% of Net Sales Product Launch Anticipated in Q1/2009 TORONTO–(HSMN NewsFeed)–Biovail Corporation (NYSE:BVF )(TSX:BVF ) today announced that a subsidiary, Biovail…
Biopharmaceuticals, Distribution
Biovail, sanofi-aventis, Aplenzin, bupropion
Pediatric Patient Treated Using RapidArc(TM) Radiotherapy Technology in Switzerland
BELLINZONA, Switzerland, Dec. 22 (HSMN NewsFeed) — A Swiss cancer clinic is among the first in the world to use a new, faster radiotherapy technology from Varian Pharmaceutical Systems (NYSE: VAR ) to treat a child patient. A 12-year-old girl with Hodgkin’s ly…
Devices, Oncology
Varian Medical laboratory Systems, RapidArc, radiotherapy, lymphoma
